BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 23777630)

  • 21. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4.
    Balog J; Thijssen PE; Shadle S; Straasheijm KR; van der Vliet PJ; Krom YD; van den Boogaard ML; de Jong A; F Lemmers RJ; Tawil R; Tapscott SJ; van der Maarel SM
    Epigenetics; 2015; 10(12):1133-42. PubMed ID: 26575099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.
    Krom YD; Thijssen PE; Young JM; den Hamer B; Balog J; Yao Z; Maves L; Snider L; Knopp P; Zammit PS; Rijkers T; van Engelen BG; Padberg GW; Frants RR; Tawil R; Tapscott SJ; van der Maarel SM
    PLoS Genet; 2013 Apr; 9(4):e1003415. PubMed ID: 23593020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
    Pirozhkova I; Petrov A; Dmitriev P; Laoudj D; Lipinski M; Vassetzky Y
    PLoS One; 2008; 3(10):e3389. PubMed ID: 18852887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
    Haynes P; Bomsztyk K; Miller DG
    Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
    Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
    Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
    Banerji CRS; Zammit PS
    EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.
    Himeda CL; Debarnot C; Homma S; Beermann ML; Miller JB; Jones PL; Jones TI
    Mol Cell Biol; 2014 Jun; 34(11):1942-55. PubMed ID: 24636994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy.
    Neguembor MV; Gabellini D
    Epigenomics; 2010 Apr; 2(2):271-87. PubMed ID: 22121874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins.
    Campbell AE; Shadle SC; Jagannathan S; Lim JW; Resnick R; Tawil R; van der Maarel SM; Tapscott SJ
    Elife; 2018 Mar; 7():. PubMed ID: 29533181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2.
    Lemmers RJ; van der Vliet PJ; Balog J; Goeman JJ; Arindrarto W; Krom YD; Straasheijm KR; Debipersad RD; Özel G; Sowden J; Snider L; Mul K; Sacconi S; van Engelen B; Tapscott SJ; Tawil R; van der Maarel SM
    Eur J Hum Genet; 2018 Jan; 26(1):94-106. PubMed ID: 29162933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
    Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
    J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A unifying genetic model for facioscapulohumeral muscular dystrophy.
    Lemmers RJ; van der Vliet PJ; Klooster R; Sacconi S; Camaño P; Dauwerse JG; Snider L; Straasheijm KR; van Ommen GJ; Padberg GW; Miller DG; Tapscott SJ; Tawil R; Frants RR; van der Maarel SM
    Science; 2010 Sep; 329(5999):1650-3. PubMed ID: 20724583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G; Huichalaf CH; Caccia R; Gabellini D
    Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
    Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
    Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei.
    Vanderplanck C; Tassin A; Ansseau E; Charron S; Wauters A; Lancelot C; Vancutsem K; Laoudj-Chenivesse D; Belayew A; Coppée F
    Skelet Muscle; 2018 Jan; 8(1):2. PubMed ID: 29329560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
    Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.